Primary transitional cell carcinoma of the prostate

Area of Science:

• Urology
• Oncology
• Pathology

Background:

• Transitional cell carcinoma (TCC) of the prostate is a rare malignancy.
• Its clinical presentation and diagnostic findings can mimic those of prostatic adenocarcinoma.

Purpose of the Study:

• To describe the clinical characteristics, diagnostic findings, and treatment outcomes of transitional cell carcinoma of the prostate.
• To differentiate TCC of the prostate from prostatic adenocarcinoma.

Main Methods:

• Review of clinical data, imaging, and pathological findings in patients diagnosed with TCC of the prostate.
• Analysis of treatment modalities and patient prognoses.

Main Results:

• TCC of the prostate typically presents as a poorly differentiated and advanced neoplasm at diagnosis.
• Osteolytic bone metastases are common, often associated with elevated serum alkaline or acid phosphatase.
• Tartrate-inhibited serum acid phosphatase fractions were not elevated.

Conclusions:

• Radical prostatectomy followed by radiation therapy represents the optimal treatment strategy for TCC of the prostate.
• Hormonal manipulation is not indicated due to the non-hormonal dependence of these neoplasms.
• The prognosis for patients with transitional cell carcinoma of the prostate is generally guarded.